Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced today that target enrollment has been achieved for the company’s pivotal Phase 3 clinical trial, CPP FAP-310, evaluating CPP-1X/sulindac in adults with familial adenomatous polyposis (FAP). FAP is a rare genetic disease that, if untreated, progresses to colorectal cancer in almost all cases. The trial has enrolled 166 patients at 21 research institutes in the United States, Canada and Europe.Continue reading
Category Archives: AZBio News
TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma treatment
Drugs target the Hedgehog cellular pathway to attack the nation’s most common skin cancer, affecting nearly 2.8 million Americans each yearContinue reading
CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes
The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path) and TransCelerate BioPharma, Inc. (“TransCelerate”) today announce the open availability of new and updated CDISC Therapeutic Area (TA) Standards in the areas of Chronic Obstructive Pulmonary Disease (COPD), Virology, and Diabetes.
Arizona Bioscience Roadmap Report for 2015 Released
By the Numbers: Arizona bioscience job growth rate continues to outpace nation; Risk capital and university startups increase; Research dollars declineContinue reading
State Compacts Enable Quality Healthcare Delivery
Arizona has a shortage of healthcare professionals. Four bills at the Arizona Legislature are designed to help address the problem.Continue reading
Midwestern University’s Institute for Healthcare Innovation Majors in Clinical Trial Collaborations.
The Institute for Healthcare Innovation (IHI) at Midwestern University (MWU) provides biomedical companies, physicians, and veterinarians a clinical research and development resource for evaluating drugs, devices, diagnostics, nutritionals, and biologics.
Continue reading
FDA Approvals Set All-Time High
2016 Healthcare Leadership Awards Finalists Announced
Meet the finalists for Healthcare Leadership Awards
Beyond DNA: TGen points the way to enhanced precision medicine with RNA sequencing
Deeper genetic analysis with RNA sequencing provides better diagnostics and treatments for patients with everything from cancer to deadly virusesContinue reading
Making LIFE Better: NYTimes chronicals the journey from the Jarvic 7 to the SynCardia Total Artificial Heart
Produced by Retro Report for The New York Times, A CHANGE OF HEART shows how the modern-day SynCardia Total Artificial Heart has come full circle from its origins as a permanent heart to successfully pioneering use as a bridge to transplant to a new FDA clinical study for permanent use. Watch the documentary and hear what this life-saving and life-changing innovation means to the most important person…a patient.